ROIVANT SCIENCES SHARES DOWN 1.4% PREMARKET; CO ANNOUNCES TOPLINE RESULTS FROM PROOF-OF-CONCEPT STUDY OF IMVT-1402 IN CUTANEOUS LUPUS ERYTHEMATOSUS

Reuters · 3d ago

Please log in to view news